Study guide · Area 1B
Providing Care: Distribution
20% of Part I · 5 competencies
Area 1B, Providing Care: Distribution, is about 20% of Part I in PEBC's 2026 blueprint. It covers the path a prescription takes: reviewing and processing it, preparing the product, verifying it, releasing it to the patient, and managing the inventory behind it. Questions test legality, appropriateness, calculations and the safety checks at each step.
A study feature written by ExamDragon, not part of the real exam. Each heading is one of this area's 5 competencies, as PEBC words it in the 2026 blueprint.
At a glance
Area 1Bof Part I, as PEBC weights it in the 2026 blueprint
- Weight
- 20%
- Competencies
- 5
- Key terms
- 9
What this guide covers, competency by competency
1.6Review and process prescriptions
- A prescription is checked for completeness: patient, date, drug, strength, dosage form, quantity or duration, directions, refills, and the prescriber's name and signature or a verifiable electronic equivalent.
- It is also checked for authenticity (signs of alteration or forgery) and clinical appropriateness: dose, indication, interactions, allergies, duplications and contraindications.
- Under the federal schedules, Schedule I drugs need a prescription; narcotics, controlled drugs and targeted substances carry added federal rules on refills, transfers and records.
- Narcotic prescriptions under the Narcotic Control Regulations cannot be refilled; a prescriber may instead authorize part-fills, with the total quantity and the interval stated.
- Error-prone notation (U for units, QD, a trailing zero such as 1.0 mg, a missing leading zero such as .5 mg) must be clarified, never guessed.
- Dose checks by weight are routine: for example amoxicillin at 80 mg/kg/day for a 15 kg child is 1,200 mg per day, 600 mg twice daily.
- The situationA prescription for a 12 kg child reads "acetaminophen 160 mg/5 mL, 10 mL q4h prn".
- Step 1Convert the volume to a dose: 10 mL x 160 mg / 5 mL = 320 mg.
- Step 2Compare with the usual dose of about 10 to 15 mg/kg: 120 to 180 mg for 12 kg.
- Step 3The dose is about twice the usual; contact the prescriber before dispensing.
- Where questions turnChecking only that the prescription is legally complete and missing that the dose is clinically wrong.
- The takeawayConvert every dose to mg/kg and compare it with a reference range before processing a pediatric prescription.
1.7Prepare products and preparations for dispensing
- Preparation includes selecting the right product by name, strength and form, counting or measuring, and labelling.
- Look-alike, sound-alike pairs (for example hydroxyzine and hydralazine) are separated on the shelf and flagged; tall man lettering helps tell them apart.
- Reconstitute powders with the exact volume of diluent the product monograph states, then label the expiry and storage after mixing.
- Non-sterile compounding follows NAPRA's Model Standards: assess the risk level, use a master formulation record, document each preparation, and assign a beyond-use date from the standards and references.
- Concentration and quantity calculations: to make 100 g of a 2% cream you need 2 g of active ingredient.
- Alligation and dilution: C1 x V1 = C2 x V2. To make 200 mL of a 1% solution from a 5% stock, use 40 mL of stock and 160 mL of diluent.
- The situationA prescriber orders 60 g of 0.5% hydrocortisone ointment. The pharmacy stocks 1% hydrocortisone ointment and a plain ointment base.
- Step 1Use C1 x V1 = C2 x V2: 1% x V1 = 0.5% x 60 g, so V1 = 30 g of the 1% ointment.
- Step 2Add 30 g of a compatible base for a total of 60 g.
- Step 3Document the formula, ingredients, lot numbers and beyond-use date, and label the product.
- Where questions turnAdding the diluent volume to the whole final volume instead of making up to it, which gives a weaker product.
- The takeawaySet up the equation from the strength you need, solve for the stock quantity, then make up the rest with diluent or base.
1.8Verify the accuracy and quality of dispensed products and preparations
- Final verification is an independent check of the product against the original prescription, not against the label typed from it.
- Check the patient, drug, strength, dosage form, quantity, directions, prescriber, and auxiliary labels, and inspect the product itself.
- Barcode scanning reduces selection errors but does not replace checking the directions and the clinical review.
- For compounded products, check the calculations, the ingredients and lots used, the appearance and the documentation.
- High-alert medications (for example insulin, opioids, anticoagulants, methotrexate, concentrated electrolytes) warrant an independent double check.
- Weekly methotrexate must be clearly labelled with the day of the week; daily dosing by mistake has caused deaths.
- The situationA technician has filled a prescription for methotrexate 2.5 mg tablets, "take 4 tablets once weekly", and labelled it "take 4 tablets daily".
- Step 1Compare the label with the original prescription and see the frequency is wrong.
- Step 2Return it for correction and check the corrected label names the day of the week.
- Step 3Record the near miss so the cause can be reviewed.
- Where questions turnChecking the product against the computer label, which repeats any error made at data entry.
- The takeawayVerify against the source document, and treat a near miss as information for the system, not a private correction.
1.9Release verified products and preparations
- Release confirms the right patient with two identifiers (for example name and date of birth) before the product leaves the pharmacy.
- Counselling at release is the last chance to catch an error: show the patient the product and confirm what it is for.
- A product may be released to an agent of the patient when that is appropriate, while keeping the patient's information confidential.
- Schedule II products are kept where the public has no access and are sold only after the pharmacist's intervention; Schedule III products are sold from the professional services area under pharmacist supervision (NAPRA model).
- Delivery and mail service must keep the product secure, within its temperature range, and traceable to the patient.
- When a patient says "this looks different", stop and check before releasing; it may be a new manufacturer or an error.
- The situationA patient picking up a refill says her blood pressure pills used to be white and these are yellow.
- Step 1Pause the release and compare the product with the prescription and the dispensing record.
- Step 2If it is a different manufacturer of the same drug, explain that, and note it so the change is expected next time.
- Step 3If it is the wrong drug or strength, correct it, apologize and follow the incident process.
- Where questions turnReassuring the patient that generics look different without first confirming that the product is in fact correct.
- The takeawayA patient's question at the counter is a safety check; take it seriously every time.
1.10Manage pharmacy inventory to ensure safe and efficient distribution
- Inventory management balances availability against waste: order points, turnover and expiry rotation (first expiry, first out).
- Refrigerated products such as vaccines and insulin are stored at 2 to 8 degrees Celsius with temperature monitoring; an excursion means quarantine and checking with the manufacturer or public health before use.
- Health Canada classifies recalls: Type I (a reasonable probability of serious harm or death), Type II (temporary or reversible harm, or a remote chance of serious harm) and Type III (unlikely to cause harm).
- Expired, damaged and recalled stock is separated from saleable stock and labelled so it cannot be dispensed.
- Narcotics, controlled drugs and targeted substances need complete purchase and dispensing records, regular counts and secure storage.
- A loss or theft of narcotics, controlled drugs or targeted substances is reported to Health Canada within 10 days of discovery.
- The situationOvernight, the vaccine fridge alarm shows the temperature reached 12 degrees Celsius for about three hours.
- Step 1Keep the affected vaccines refrigerated but quarantined and labelled "do not use".
- Step 2Record the time, duration and maximum temperature, and contact the manufacturer or public health as required for advice on use.
- Step 3Fix the cause, then review the alarm and response process.
- Where questions turnThrowing away exposed vaccines straight away (which may be wasteful) or using them as if nothing happened (which may be unsafe).
- The takeawayDo not discard or use exposed vaccines on your own judgment: quarantine, document and get advice.
Key terms
- DIN
- Drug Identification Number, the eight-digit number Health Canada assigns to a drug product authorized for sale.
- NPN
- Natural Product Number, assigned to a licensed natural health product.
- Part-fill
- Dispensing part of the total quantity of a prescription at intervals, as the prescriber authorizes.
- LASA
- Look-alike, sound-alike: drug names or packages easily confused.
- Tall man lettering
- Capitals inside drug names to highlight differences, such as hydrOXYzine and hydrALAZINE.
- Beyond-use date
- The date after which a compounded preparation should not be used.
- Cold chain
- Keeping temperature-sensitive products within their range from manufacturer to patient.
- Recall Type I
- Health Canada's most serious recall class: a reasonable probability of serious harm or death.
- Two identifiers
- Two independent facts, such as name and date of birth, used to confirm a patient's identity.
Show the answer
10% x V1 = 2% x 250 mL, so V1 = 50 mL of stock made up to 250 mL.
Built to PEBC's 2026 Qualifying Examination blueprint. The explanations, worked examples and traps are ExamDragon's own. Every source this path is built on.
